CoreCap Advisors’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
LMFP
HGIM
DC
CF
MIHAS
CoreCap Advisors's ELV Position: Q2 2026 in Review
CoreCap Advisors increased its Elevance Health (ELV) stake by 10% in Q2 2026, buying an estimated $21.1K and bringing the position to 600 shares worth $232K. The position accounts for 0.01% of the portfolio, ranked #812.
CoreCap Advisors first reported a position in ELV in Q4 2021 and has held it in 12 quarters since. 413 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- CoreCap Advisors held 600 shares of Elevance Health worth $232K as of Q2 2026.
- CoreCap Advisors bought 57 Elevance Health shares in Q2 2026, an estimated $21.1K.
- Elevance Health made up 0.01% of CoreCap Advisors's portfolio in Q2 2026, its #812 holding.
- CoreCap Advisors first reported a position in Elevance Health in Q4 2021 and has held it in 12 quarters since.
- 413 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on CoreCap Advisors's 13F filing for Q2 2026, filed 6 Jul 2026.